Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzeon QoL in HIV-1
NCT00232908Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2004
- Primary completion
- Oct 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of enfuvirtide in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Roche. Started Jun 2004; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00232908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00232908.